Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 28.04.2025 1 Am J Dermatopathol 5 BMC Cancer 2 Cancer 4 Cancer Lett 9 Clin Dermatol 12 Clin Exp Dermatol 3 Int J Cancer 5 Int J Dermatol 2 J Cutan Pathol 4 J Dermatol 11 J Invest Dermatol 1 JAAPA 1 Mycoses 1 N Engl J Med 6 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. ROBSON A, Bakr F, Cabecadas J
   Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges.
   Am J Dermatopathol. 2024;46:399-409.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ESMAELI M, Dehabadi MD, Khaleghi AA
   Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature.
   BMC Cancer. 2025;25:772.
   PubMed         Abstract available
   
   
3. RAVEENDRAN C, Meloot SS, Yadev IP
   Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study.
   BMC Cancer. 2025;25:753.
   PubMed         Abstract available
   
   
4. GLORY A, Patocskai E, Wong P
   Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients.
   BMC Cancer. 2025;25:748.
   PubMed         Abstract available
   
   
5. ZHANG Y, Wang H, Wang Y, Ma B, et al
   FOXO1 mediates miR-99a-5p/E2F7 to restrain breast cancer cell proliferation and induce apoptosis.
   BMC Cancer. 2025;25:747.
   PubMed         Abstract available
   
   
6. GUPTA H, Raghubansi A, Bharat, Sharma K, et al
   Targeting GSK3beta and signaling pathways in breast cancer: role of individual members of miR- 23/24/27 cluster.
   BMC Cancer. 2025;25:737.
   PubMed         Abstract available
   
   

   
   Cancer

7. ZOPE M, Sullivan R, Gutnik L
   Fragmented care and misaligned incentives of stakeholders in breast cancer care for the uninsured in the United States.
   Cancer. 2025;131:e35878.
   PubMed         Abstract available
   
   
8. PEARCE A, Carter S, Frazer HM, Houssami N, et al
   Implementing artificial intelligence in breast cancer screening: Women's preferences.
   Cancer. 2025;131:e35859.
   PubMed         Abstract available
   
   

   
   Cancer Lett

9. KUNDU M, Greer YE, Lobanov A, Ridnour L, et al
   TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells.
   Cancer Lett. 2025;620:217692.
   PubMed         Abstract available
   
   
10. HAYKAL MM, Rodrigues-Ferreira S, El Botty R, Sourd L, et al
    Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers.
    Cancer Lett. 2025;620:217665.
    PubMed         Abstract available
    
    
11. TANG R, Xu X, Yang W, Yu W, et al
    Corrigendum to "MED27 promotes melanoma growth by targeting AKT/MAPK and NF/kappaB/iNOS signaling pathway" [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421].
    Cancer Lett. 2025;623:217717.
    PubMed        
    
    
12. TIAN H, Chen Y, Dong X, Fan X, et al
    The m(6)A hypermethylation-induced PIR overexpression regulates H3K4me3 and promotes Tumorigenesis of Uveal Melanoma.
    Cancer Lett. 2025 Apr 17:217729. doi: 10.1016/j.canlet.2025.217729.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

13. ABDELWAHAB SI, Farasani A, Alfaifi HA, Alamer AS, et al
    A comprehensive bibliometric analysis of prurigo nodularis literature (1951-2024): Key contributors, trends, and thematic evolution.
    Clin Dermatol. 2025;43:231-241.
    PubMed         Abstract available
    
    
14. ODELL ID
    Genetic and molecular drivers of scleroderma pathogenesis.
    Clin Dermatol. 2025;43:153-159.
    PubMed         Abstract available
    
    
15. VESELY MD
    Mixed and undifferentiated autoimmune connective tissue diseases.
    Clin Dermatol. 2025;43:160-165.
    PubMed         Abstract available
    
    
16. NELSON CA, Leventhal JS
    Life-threatening dermatoses.
    Clin Dermatol. 2025;43:201-210.
    PubMed         Abstract available
    
    
17. ROWE E, Zubek AE
    Nail disorders as clues to systemic disease.
    Clin Dermatol. 2025;43:191-200.
    PubMed         Abstract available
    
    
18. RAMACHANDRAN S, Little AJ, Gehlhausen JR
    Lupus erythematosus and dermatomyositis.
    Clin Dermatol. 2025;43:147-152.
    PubMed         Abstract available
    
    
19. KO CJ, McNiff JM
    The art of dermatopathology.
    Clin Dermatol. 2025;43:211-215.
    PubMed         Abstract available
    
    
20. EISENSTEIN A, Johnston M, Laird M, Perkins S, et al
    The art of dermatology: Lessons learned from master morphologist, Irwin M. Braverman, MD.
    Clin Dermatol. 2025;43:144-146.
    PubMed         Abstract available
    
    
21. CHOATE KA
    Irwin M. Braverman, MD: A pillar of dermatology.
    Clin Dermatol. 2025;43:142-143.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

22. GAMBICHLER T, Gencik M, Schmidt J, Kekelyova P, et al
    Two novel variants of SPINK5 mutations in a boy with ichthyosis linearis circumflexa and atopy.
    Clin Exp Dermatol. 2025 Apr 21:llaf125. doi: 10.1093.
    PubMed        
    
    
23. KOONER A, Hamburger ND, Sekhon RA, Ira S, et al
    The Impact of STDs on Basal Cell Carcinoma Risk: A Case-Control Investigation.
    Clin Exp Dermatol. 2025 Apr 23:llaf177. doi: 10.1093.
    PubMed        
    
    
24. SINGH S, Rana MK, Kapatia G, Thakur V, et al
    Skin Oncology.
    Clin Exp Dermatol. 2025 Apr 23:llaf182. doi: 10.1093.
    PubMed        
    
    
25. GILAD Y, Simpson EL, Apfelbacher C, Spuls PI, et al
    How do atopic dermatitis trialists perceive the HOME Core Outcome Set? - a survey study from the HOME initiative.
    Clin Exp Dermatol. 2025 Apr 25:llaf191. doi: 10.1093.
    PubMed        
    
    
26. GHERARDINI J, Akhundlu A, Gompels M, Verbinnen A, et al
    Pilot evidence that topically applied triiodothyronine (T3) can stimulate hair growth in human scalp skin.
    Clin Exp Dermatol. 2025 Apr 25:llaf190. doi: 10.1093.
    PubMed        
    
    
27. SWAIN E, Haughton R, Palmer V, Obeime I, et al
    Shared decision-making in central centrifugal cicatricial alopecia.
    Clin Exp Dermatol. 2025;50:998-1001.
    PubMed         Abstract available
    
    
28. GAO J, Li Q, Huang H, Yu S, et al
    Combined tofacitinib citrate and 308-nm excimer laser treatment for vitiligo: a pilot study.
    Clin Exp Dermatol. 2025;50:940-945.
    PubMed         Abstract available
    
    
29. BISHNOI A, Sharma A, Baskaran N, Mehta H, et al
    Acquired autoinflammatory disorders: a dermatologist's perspective.
    Clin Exp Dermatol. 2025;50:928-939.
    PubMed         Abstract available
    
    
30. GAMISSANS M, Muntaner-Virgili C, Penin RM, Marcoval J, et al
    Characteristics of spontaneous regression of Merkel cell carcinoma: a retrospective analysis of patient and tumour features.
    Clin Exp Dermatol. 2025;50:994-997.
    PubMed         Abstract available
    
    
31. POTESTIO L, Feo F, Martora F, Megna M, et al
    The use of ChatGPT in the dermatological field: a narrative review.
    Clin Exp Dermatol. 2025;50:921-927.
    PubMed         Abstract available
    
    
32. MOLINELLI E, De Simoni E, Dragonetti ML, Belleggia S, et al
    The influence of hormonal combined contraceptive in the onset of hidradenitis suppurativa: a retrospective cohort study.
    Clin Exp Dermatol. 2025;50:1002-1005.
    PubMed         Abstract available
    
    
33. AGARWAL A, Bansal P, Madhual S, Panda M, et al
    Modified intralesional aciclovir treatment in the management of recalcitrant palmoplantar and ungual warts: a case series of 14 patients.
    Clin Exp Dermatol. 2025;50:1009-1013.
    PubMed         Abstract available
    
    

    
    Int J Cancer

34. ZAHWE M, Bendahhou K, Eser S, Mukherji D, et al
    Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022.
    Int J Cancer. 2025 Jan 10. doi: 10.1002/ijc.35325.
    PubMed         Abstract available
    
    
35. GOLANI R, Kagenaar E, Jegu J, Belot A, et al
    Socio-economic inequalities in second primary cancer incidence: A competing risks analysis of women with breast cancer in England between 2000 and 2018.
    Int J Cancer. 2025 Jan 24. doi: 10.1002/ijc.35320.
    PubMed         Abstract available
    
    
36. BENDINELLI B, Danza G, Assedi M, Villanelli F, et al
    Circulating sex hormones and volumetric breast density: A prospective study in women from the EPIC Florence cohort.
    Int J Cancer. 2025;156:2294-2302.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

37. KEMENY L
    Editor's Highlights-May 2025.
    Int J Dermatol. 2025;64:787-788.
    PubMed         Abstract available
    
    
38. MARRON SE, Gracia-Cazana T, Sampogna F, Schut C, et al
    Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe.
    Int J Dermatol. 2025;64:861-869.
    PubMed         Abstract available
    
    
39. SOBOTKOVA T, Hugo J, Salavec M, Kojanova M, et al
    Efficacy, Safety, and Drug Survival During the First Year of Biologic Therapy for Psoriasis in Elderly Versus Younger Patients.
    Int J Dermatol. 2025 Apr 24. doi: 10.1111/ijd.17814.
    PubMed         Abstract available
    
    
40. WOLLENBERG A, Barbarot S, Torrelo A
    Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies.
    Int J Dermatol. 2025 Apr 23. doi: 10.1111/ijd.17793.
    PubMed         Abstract available
    
    
41. TOUNOUGA DN, Guicheney M, Contis A, Dumas PY, et al
    Bifocal Nocardiosis Mimicking Neutrophilic Dermatosis in an Immunocompromised Patient.
    Int J Dermatol. 2025 Apr 22. doi: 10.1111/ijd.17808.
    PubMed        
    
    

    
    J Cutan Pathol

42. LEE JJ, Angra D, Sperling LC
    Contact Dermatitis of the Scalp Also Demonstrates Sebaceous Gland Atrophy.
    J Cutan Pathol. 2025 Apr 23. doi: 10.1111/cup.14814.
    PubMed        
    
    
43. BHATTARAI D, Banday AZ, Joshi S, Adhikari RC, et al
    Griscelli Syndrome Type 2 Secondary to a Novel RAB27A Variant Presenting With Dermatitis.
    J Cutan Pathol. 2025 Apr 22. doi: 10.1111/cup.14812.
    PubMed        
    
    

    
    J Dermatol

44. TOYOSHIMA R, Shibata S, Kakumoto T, Sato S, et al
    A Case of Parkinsonism Manifested by Exacerbation of Generalized Pustular Psoriasis.
    J Dermatol. 2025 Apr 21. doi: 10.1111/1346-8138.17750.
    PubMed        
    
    
45. NAKAJIMA K, Miyagaki T, Okano T, Kadono T, et al
    Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study.
    J Dermatol. 2025 Apr 22. doi: 10.1111/1346-8138.17760.
    PubMed        
    
    
46. NAKAZATO S, Fujita Y, Anan T
    Microcystic Pseudoglandular Cutaneous Neurofibroma: The First Japanese Case of a Rare Neurofibroma Variant.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17761.
    PubMed        
    
    
47. TESHIMA R, Saito-Sasaki N, Hara N, Itamura M, et al
    Adult-Onset Langerhans Cell Histiocytosis Mimicking Erosive Pustular Dermatosis of the Scalp.
    J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17762.
    PubMed        
    
    

    
    J Invest Dermatol

48. ZHU Y, Zhang C
    Between Light and Shadow: The Enigma of Nonlesional Skin in Vitiligo.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00127.
    PubMed        
    
    
49. MIECZKOWSKI K, Bakiri L, Griss J, Wagner EF, et al
    A sex-specific anti-inflammatory role for p62 in psoriasis-like disease.
    J Invest Dermatol. 2025 Apr 19:S0022-202X(25)00413.
    PubMed         Abstract available
    
    
50. MERHI R, Boniface K, Seneschal J
    Unveiling the Unseen: Exploring Cellular Dynamics in Nonlesional Vitiligo Skin.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00128.
    PubMed         Abstract available
    
    
51. EYLENBOSCH A, Lambert JLW
    One Step Closer to Personalized Dosing of Biologics in Psoriasis.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00375.
    PubMed        
    
    
52. OKUNO R, Hasegawa S, Hasebe Y, Kawagishi-Hotta M, et al
    Site-specific expression of HOXA genes in skin and its effect on skin elasticity.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00417.
    PubMed         Abstract available
    
    
53. RIACHI M, Bryant D, Ellis J, Hughes C, et al
    Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseases.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00414.
    PubMed         Abstract available
    
    
54. SANABRIA-DE LA TORRE R, Montero-Vilchez T, Garcia-Gavin J, Arias-Santiago S, et al
    Current Insights on Lipidomics in Dermatology: A Systematic Review.
    J Invest Dermatol. 2025;145:1105-1116.
    PubMed         Abstract available
    
    
55. DOELEMAN T, Brussee S, Hondelink LM, Westerbeek DWF, et al
    Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept Study.
    J Invest Dermatol. 2025;145:1127-1134.
    PubMed         Abstract available
    
    
56. YOSHIMOTO N, Muramastsu K, Ito T, Zheng M, et al
    Type XVII Collagen-Specific CD4(+) T Cells Induce Bullous Pemphigoid by Producing IL-5.
    J Invest Dermatol. 2025;145:1092-1104.
    PubMed         Abstract available
    
    
57. KUCERA K, Zenzola N, Hudspeth A, Dubnicka M, et al
    Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products.
    J Invest Dermatol. 2025;145:1147-1154.
    PubMed         Abstract available
    
    
58. JIA BB, Sun BK, Lee EY, Ren B, et al
    Emerging Techniques in Spatial Multiomics: Fundamental Principles and Applications to Dermatology.
    J Invest Dermatol. 2025;145:1017-1032.
    PubMed         Abstract available
    
    

    
    JAAPA

59. ALIX P, Moseley G, Chazin S, Polley C, et al
    Squamous cell carcinoma arising from chronic enteroatmospheric fistula.
    JAAPA. 2025;38:32-34.
    PubMed         Abstract available
    
    

    
    Mycoses

60. CHEN YC, Ou JH, Wu CJ, Kuo SF, et al
    Clinical and Hospital Environmental Fusarium in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Phylogenetic Analyses.
    Mycoses. 2025;68:e70056.
    PubMed         Abstract available
    
    

    
    N Engl J Med

61. DUBE U, Eichenfield D
    Cutaneous Leishmaniasis.
    N Engl J Med. 2025;392:e41.
    PubMed        
    
    

    
    PLoS One

62. KIVUYO N, Akoko L, Mutajwaha JOG, Haule C, et al
    Dismal pathological response to neoadjuvant chemotherapy in stage III breast cancer patients in Tanzania: A retrospective review.
    PLoS One. 2025;20:e0321187.
    PubMed         Abstract available
    
    
63. BAIDOO TG, Rodrigo H
    Data-driven survival modeling for breast cancer prognostics: A comparative study with machine learning and traditional survival modeling methods.
    PLoS One. 2025;20:e0318167.
    PubMed         Abstract available
    
    
64. RAMONDA R, Ometto F, Striani G, Cozzi G, et al
    Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept study.
    PLoS One. 2025;20:e0321140.
    PubMed         Abstract available
    
    
65. ALI SH, Fallon N, Giesbrecht T, Stancak A, et al
    Affective touch reduces histamine evoked itch experience.
    PLoS One. 2025;20:e0319006.
    PubMed         Abstract available
    
    
66. KIM JS, Shah AA, Hummers LK, Zeger SL, et al
    Separated or joint models of repeated multivariate data to estimate individuals' disease trajectories with application to scleroderma.
    PLoS One. 2025;20:e0320414.
    PubMed         Abstract available
    
    
67. FADHAL E, Raza A, Rocha EM, Alfwzan WF, et al
    Dynamical analysis of scabies delayed epidemic model with second-order global stability.
    PLoS One. 2025;20:e0319095.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

68. FOFFI E, Rugolo F, Ramamurthy N, Haight J, et al
    B cell-derived acetylcholine mitigates skin inflammation in mice through alpha9 nicotinic acetylcholine receptor-mediated signaling.
    Proc Natl Acad Sci U S A. 2025;122:e2501960122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.